Tag: Prescription Drugs

At dose of 125 mg/kg body weight, oral infigratinib results in increased annualized height velocity and z score

Findings seen in patients following myocardial infarction

Associations especially strong in patients who are frail or have chronic kidney disease

Reduction seen in recurrent nephrolithiasis events for those receiving SGLT-2 inhibitors versus GLP-1 RAs, DPP-4 inhibitors

Findings seen in patients with ischemic stroke; associations were significant after multivariable adjustment

Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion

Inavolisib leads to significantly longer progression-free survival, with no increase seen in incidence of toxic events

Findings seen in patients with IgA nephropathy, compared with placebo

Inhaled corticosteroid with short-acting β agonists or long-acting β agonist formoterol linked to reduction in exacerbations, improved control

Guidelines include 52 recommendations on evaluation, pharmacotherapy, invasive interventions, and nonpharmacologic interventions